Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
GlaxoSmithKline and the venture capital firm Avalon Ventures have formed their second and third companies as part of a collaboration that began in 2013 to jointly invest up to $495 million in 10 new firms. Sitari Pharmaceuticals was formed last November to target celiac disease. The partners now have created Silarus Therapeutics, which is targeting iron disorders using intellectual property from UCLA, and Thyritope Biosciences, a thyroid disease firm based on technology from UC Santa Barbara. Both will receive up to $10 million in funding plus R&D support.
This article has been sent to the following recipient: